Company intelligence
AlphaLife Sciences
Software Development
Iselin, US
11–50 employees
5 public signals
About AlphaLife Sciences
AlphaLife Sciences, a leader in Agentic AI-driven clinical development, advances automated medical writing and regulatory documentation through its AuroraPrime platform, driving efficiency across therapeutic areas. As Microsoft's Global AI Content Automation Partner for Life Sciences, and with support from Johnson & Johnson Innovation JLABS, Google for Startups, the Nvidia Inception Program, and Veeva's AI Program, AlphaLife Sciences accelerates drug R&D and regulatory submissions, helping to deliver life-saving treatments worldwide.
Verified activity
Signals from AlphaLife Sciences
5 published signals
Presence & Recognition
AlphaLife Sciences hosted a DIA webinar panel on September 17 to explain what actually changed, and where CMC teams should still be cautious.
Reported by AlphaLife Sciences
Research & Knowledge
AlphaLife Sciences published AuroraPrime RMA 2026.08.30 focusing on handoffs in regulatory affairs, including finding information in associated documents, working with TFLs in a CSR, reusing approved TFLs for a Lay Summary, and expanding a CMC project.
Reported by AlphaLife Sciences
Presence & Recognition
AlphaLife Sciences will be exhibiting at CDISC US Interchange 2026 in Denver in one month.
Reported by AlphaLife Sciences